- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
In this piece from his blog, Barry Ritholtz calls for an SEC investigation into the alleged cyber-stalking of OSTK critics.
An infamous bear turns cautiously bullish. Here are ten reasons why.
An infamous bear turns cautiously bullish.